Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
CB1 Cannabinoid Receptor Signaling and Biased Signaling
by
Leo, Luciana M.
, Abood, Mary E.
in
Allosteric Site
/ Apoptosis
/ biased signaling
/ cannabinoid
/ Cannabinoid Receptor Agonists - chemistry
/ CB1
/ Central Nervous System - metabolism
/ Cognitive ability
/ FDA approval
/ functional selectivity
/ G-protein
/ Humans
/ Indoles - chemistry
/ Investigations
/ Ischemia
/ Ligands
/ Marijuana
/ Metabolic disorders
/ Models, Molecular
/ Nervous system
/ Neurons
/ Pain
/ Physiology
/ Piperidines - chemistry
/ Post traumatic stress disorder
/ Pregnenolone - chemistry
/ Protein Binding
/ Protein Conformation
/ Proteins
/ Receptor, Cannabinoid, CB1 - chemistry
/ Review
/ Signal Transduction
/ Tetrahydrocannabinol
/ THC
/ β-arrestin
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
CB1 Cannabinoid Receptor Signaling and Biased Signaling
by
Leo, Luciana M.
, Abood, Mary E.
in
Allosteric Site
/ Apoptosis
/ biased signaling
/ cannabinoid
/ Cannabinoid Receptor Agonists - chemistry
/ CB1
/ Central Nervous System - metabolism
/ Cognitive ability
/ FDA approval
/ functional selectivity
/ G-protein
/ Humans
/ Indoles - chemistry
/ Investigations
/ Ischemia
/ Ligands
/ Marijuana
/ Metabolic disorders
/ Models, Molecular
/ Nervous system
/ Neurons
/ Pain
/ Physiology
/ Piperidines - chemistry
/ Post traumatic stress disorder
/ Pregnenolone - chemistry
/ Protein Binding
/ Protein Conformation
/ Proteins
/ Receptor, Cannabinoid, CB1 - chemistry
/ Review
/ Signal Transduction
/ Tetrahydrocannabinol
/ THC
/ β-arrestin
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
CB1 Cannabinoid Receptor Signaling and Biased Signaling
by
Leo, Luciana M.
, Abood, Mary E.
in
Allosteric Site
/ Apoptosis
/ biased signaling
/ cannabinoid
/ Cannabinoid Receptor Agonists - chemistry
/ CB1
/ Central Nervous System - metabolism
/ Cognitive ability
/ FDA approval
/ functional selectivity
/ G-protein
/ Humans
/ Indoles - chemistry
/ Investigations
/ Ischemia
/ Ligands
/ Marijuana
/ Metabolic disorders
/ Models, Molecular
/ Nervous system
/ Neurons
/ Pain
/ Physiology
/ Piperidines - chemistry
/ Post traumatic stress disorder
/ Pregnenolone - chemistry
/ Protein Binding
/ Protein Conformation
/ Proteins
/ Receptor, Cannabinoid, CB1 - chemistry
/ Review
/ Signal Transduction
/ Tetrahydrocannabinol
/ THC
/ β-arrestin
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
CB1 Cannabinoid Receptor Signaling and Biased Signaling
2021
Request Book From Autostore
and Choose the Collection Method
Overview
The CB1 cannabinoid receptor is a G-protein coupled receptor highly expressed throughout the central nervous system that is a promising target for the treatment of various disorders, including anxiety, pain, and neurodegeneration. Despite the wide therapeutic potential of CB1, the development of drug candidates is hindered by adverse effects, rapid tolerance development, and abuse potential. Ligands that produce biased signaling—the preferential activation of a signaling transducer in detriment of another—have been proposed as a strategy to dissociate therapeutic and adverse effects for a variety of G-protein coupled receptors. However, biased signaling at the CB1 receptor is poorly understood due to a lack of strongly biased agonists. Here, we review studies that have investigated the biased signaling profile of classical cannabinoid agonists and allosteric ligands, searching for a potential therapeutic advantage of CB1 biased signaling in different pathological states. Agonist and antagonist bound structures of CB1 and proposed mechanisms of action of biased allosteric modulators are used to discuss a putative molecular mechanism for CB1 receptor activation and biased signaling. Current studies suggest that allosteric binding sites on CB1 can be explored to yield biased ligands that favor or hinder conformational changes important for biased signaling.
Publisher
MDPI AG,MDPI
This website uses cookies to ensure you get the best experience on our website.